← All stocks

ARTIVION, INC.

AORT Net selling
CIK 0000784199 #2312 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$20.73M
$0.00 on a plan · $8.15M straight out of an exercise
Sold at will
$12.58M
48 of 64 sales
Net
−$20.73M
−$12.58M against sales at will

By person

15 insiders · 64 transactions
26.2×

J. Patrick Mackin holds 26.2 times base salary in stock. $21.91M of shares against $835.15K in salary for 2025.

Salary from the company's own proxy. The shares are what J. Patrick Mackin last reported holding, valued at $24.97, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mackin James P
President & CEO
$9.72M (9)
−$9.72M
877,275
1.80%
$21.91M
+24.3%
Stanton Marshall S.
SVP, Clinical & MD Affair
$3.43M (13) scheduled
−$3.43M
60,097
0.1233%
$1.50M
−29.6%
Holloway Jean F
SVP, General Counsel
$2.54M (13)
−$2.54M
184,118
0.3776%
$4.60M
+12.2%
Davis John E
Chief Commercial Officer
$1.75M (9)
−$1.75M
230,794
0.4734%
$5.76M
+37.4%
GREEN ANDREW M
SVP, Regulatory and Quality
$1.43M (6) scheduled
−$1.43M
40,160
0.0824%
$1.00M
−40.8%
Horton Amy
VP, Chief Accounting Officer
$870.06K (8)
−$870.06K
139,088
0.2853%
$3.47M
−0.6%
Berry Lance A
EVP, COO, CFO & Treasurer
$803.21K (5)
−$803.21K
210,112
0.4309%
$5.25M
+165.7%
Hoff Elizabeth A
Director
$189.41K (1)
−$189.41K
34,765
0.0713%
$868.08K
+38.7%
BEVEVINO DANIEL J
Director
157,637
0.3233%
$3.94M
+9.7%
ACKERMAN THOMAS F
Director
157,472
0.3230%
$3.93M
+9.7%
Salveson Jon W
Director
137,416
0.2818%
$3.43M
+11.3%
Bullock James
Director
76,223
0.1563%
$1.90M
+22.3%
Burbank Jeffrey H
Director
61,372
0.1259%
$1.53M
+29.3%
Borgstrom Marna P
Director
56,938
0.1168%
$1.42M
+33.1%
SEMEDO ANTHONY B.
Director
46,960
0.0963%
$1.17M
+39.9%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 16
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 690,931
History held since 13 Sep 2016